Regarding the literature indicating that Saos-2 cells express PDE4 [42,43] and our own data showing that MNNG cells express this enzyme, our study supports the hypothesis that anti-PDE4 molecules might be used as putative anti-cancer agents in osteosarcoma. This evidence concerns the gene PDE4A and osteosarcoma.